Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion type Assertion NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_head.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion description "[The approach of inhibiting the hepatic GR may be an advantageous treatment paradigm for individuals with type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_provenance.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion evidence source_evidence_predicted NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_provenance.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion SIO_000772 17292727 NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_provenance.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion wasDerivedFrom rgd-2016 NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_provenance.
- NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_assertion wasGeneratedBy ECO_0000218 NP60821.RAaJmR70DwVQgagqEo8eE_gtsroNQuyTxn82YFcIpexQo130_provenance.